Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Creatine in Female Methamphetamine Users
NCT02192931Phase 4Completed
- Start
- Sep 2014
- Primary completion
- Jan 2023
- Modality
- Recombinant Proteins and Enzymes, Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of creatine in methamphetamine use disorder (MUD), major depressive disorder (MDD). Started Sep 2014; status: completed.
02
Drugs
creatine
03
Conditions
methamphetamine use disorder (MUD)major depressive disorder (MDD)
Beyond the preview
Go deeper on NCT02192931.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02192931.